Charles Schwab Portfolio holdings
Charles Schwab Corporation, founded in 1971 by Charles R. Schwab and headquartered in Westlake, Texas, is a leading financial services firm that revolutionized retail investing by offering low-cost brokerage services. Initially disrupting the industry with discount commissions, it has grown into a powerhouse providing a wide array of services, including trading platforms, robo-advisors, retirement accounts, and banking products, managing hundreds of billions in client assets. Known for its user-friendly technology and customer-centric approach, Schwab caters to individual investors, financial advisors, and institutions, notably expanding through its 2020 acquisition of TD Ameritrade. With a mission to democratize investing, Charles Schwab remains a dominant force in the shift toward accessible, self-directed wealth management.
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
IBM
IBM
|
+$120M |
| 2 |
Apple
AAPL
|
+$107M |
| 3 |
Medtronic
MDT
|
+$99.1M |
| 4 |
AGN
Allergan plc
AGN
|
+$98.7M |
| 5 |
Qualcomm
QCOM
|
+$91.9M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
AGN
Allergan Inc
AGN
|
+$166M |
| 2 |
COV
COVIDIEN PLC COM SHS NEW (IRELAND)
COV
|
+$111M |
| 3 |
AT&T
T
|
+$78.6M |
| 4 |
Yum! Brands
YUM
|
+$57.6M |
| 5 |
PNC Financial Services
PNC
|
+$49.6M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Healthcare | 14.93% |
| 2 | Technology | 13.76% |
| 3 | Financials | 13.26% |
| 4 | Industrials | 10.88% |
| 5 | Consumer Discretionary | 9.09% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
1676
iShares Micro-Cap ETF
IWC
$1.5B
| $3.91M | 0.01% |
49,493
+768
| +2% | +$59.1K |
|
|
NEWP
1677
DELISTED
NEWPORT CORP
NEWP
| $3.91M | 0.01% |
205,341
+5,512
| +3% | +$107K |
|
|
ASRT
1678
DELISTED
Assertio
ASRT
| $3.91M | 0.01% |
2,909
+209
| +8% | +$257K |
|
1679
National CineMedia
NCMI
$252M
| $3.91M | 0.01% |
25,892
+2,845
| +12% | +$424K |
|
1680
Astronics
ATRO
$4.57B
| $3.9M | 0.01% |
96,532
+4,473
| +5% | +$152K |
|
1681
Ormat Technologies
ORA
$6.98B
| $3.88M | 0.01% |
102,099
+42,002
| +70% | +$1.32M |
|
1682
SunCoke Energy
SXC
$788M
| $3.88M | 0.01% |
259,638
+30,014
| +13% | +$512K |
|
|
IO
1683
DELISTED
ION Geophysical Corporation
IO
| $3.87M | 0.01% |
118,906
+17,978
| +18% | +$645K |
|
1684
Alaunos Therapeutics
TCRT
$4.86M
| $3.87M | 0.01% |
2,394
-31
| -1% | -$45.9K |
|
1685
Advanced Energy
AEIS
$13.2B
| $3.86M | 0.01% |
150,556
+28,827
| +24% | +$733K |
|
1686
Standex International
SXI
$3.97B
| $3.86M | 0.01% |
47,015
+7,267
| +18% | +$538K |
|
1687
Stepan Co
SCL
$1.48B
| $3.85M | 0.01% |
92,375
+12,950
| +16% | +$516K |
|
1688
Comfort Systems
FIX
$60.8B
| $3.85M | 0.01% |
182,791
+31,498
| +21% | +$561K |
|
|
SCLN
1689
DELISTED
Sciclone Pharmaceuticals Inc
SCLN
| $3.84M | 0.01% |
433,333
+72,064
| +20% | +$574K |
|
|
KKD
1690
DELISTED
KRISPY KREME DOUGHNUTS INC
KKD
| $3.84M | 0.01% |
191,958
+15,337
| +9% | +$312K |
|
|
KERX
1691
DELISTED
Keryx Biopharmaceuticals Inc
KERX
| $3.83M | 0.01% |
301,153
+41,205
| +16% | +$530K |
|
|
CVSA
1692
Covista Inc
CVSA
$4.49B
| $3.83M | 0.01% |
114,835
+15,252
| +15% | +$592K |
|
|
ESGR
1693
DELISTED
Enstar Group
ESGR
| $3.81M | 0.01% |
26,890
+1,407
| +6% | +$197K |
|
|
AVG
1694
DELISTED
AVG Technologies N.V.
AVG
| $3.81M | 0.01% |
176,068
+124,968
| +245% | +$2.63M |
|
|
HF
1695
DELISTED
HFF Inc.
HF
| $3.81M | 0.01% |
101,511
+4,483
| +5% | +$161K |
|
|
TUMI
1696
DELISTED
TUMI HLDGS INC COM
TUMI
| $3.81M | 0.01% |
155,792
+8,109
| +5% | +$185K |
|
1697
Erie Indemnity
ERIE
$13.4B
| $3.81M | 0.01% |
43,657
+4,066
| +10% | +$360K |
|
|
GNCMA
1698
DELISTED
GCI Liberty, Inc. Class A-1 Common Stock
GNCMA
| $3.81M | 0.01% |
241,554
+90,112
| +60% | +$1.32M |
|
|
RSE
1699
DELISTED
ROUSE PPTYS INC COM (DE)
RSE
| $3.8M | 0.01% |
200,517
+21,603
| +12% | +$404K |
|
1700
Rush Enterprises Class A
RUSHA
$9.62B
| $3.8M | 0.01% |
312,327
+27,767
| +10% | +$351K |
|
Similar funds
Charles Schwab's Q1 2015 Portfolio in Review
As of Q1 2015, Charles Schwab held 3,139 positions worth $71.1B, up 6.7% from $66.7B the previous quarter. Its ten largest holdings account for 14% of the portfolio.
Charles Schwab deployed $3.65B of net new capital in Q1 2015, opening 29 new positions and adding to 2,392 existing holdings. Its largest new stake was Qorvo: 519,290 shares worth $41.4M.
By sector, the portfolio is most concentrated in Healthcare at 15% of assets, up from 14% a quarter earlier, followed by Technology and Financials.
On the sell side, the largest reduction was AT&T, an estimated $78.6M trimmed.
- Charles Schwab's largest Q1 2015 buy was Qorvo: 519,290 shares worth $41.4M.
- Charles Schwab added most to IBM in Q1 2015, an estimated $120M increase.
- Charles Schwab's biggest Q1 2015 reduction was AT&T, cutting an estimated $78.6M.
- Charles Schwab fully exited Allergan Inc in Q1 2015, selling an estimated $166M.
- Charles Schwab's ten largest holdings make up 14% of its $71.1B portfolio in Q1 2015.
- Charles Schwab opened 29 new positions and closed 57 in Q1 2015.
- Charles Schwab's portfolio value rose 6.7% quarter-over-quarter to $71.1B.
Based on Charles Schwab's 13F filing for Q1 2015, filed 14 May 2015.